Clinical trial
ICMR-Indiaclen Trial on Amoxycillin vs Cotrimoxazole for Non-Severe Pneumonia
NCT00396526 · King George's Medical University, Other · Completed
Key facts
| NCT number | NCT00396526 |
|---|---|
| Title | ICMR-Indiaclen Trial on Amoxycillin vs Cotrimoxazole for Non-Severe Pneumonia |
| Official title | Effectiveness of 3 Day Amoxycillin Versus 5 Day co-Trimoxazole in the Treatment of Non-Severe Pneumonia in Children Aged 2- 59 Months of Age: - A Multi-Centric Open Labeled Trial |
| Lead sponsor | King George's Medical University, Other |
| Collaborators | Indian Council of Medical Research United States Agency for International Development (USAID) U.S. Fed |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-Severe Pneumonia, Under-Fives, Children |
| Intervention type | Drug |
| Interventions | Oral Co-trimoxazole (8mg/kg/day trimithoprim) twice a day for five days vs. oral amoxycillin (20 mg/kg/day) thrice a day for three days. |
| Enrollment | 2,000 |
| Start date | Apr 1, 2004 |
| Completion | Apr 1, 2006 |
| First posted | Nov 7, 2006 |
| Last update posted | Dec 7, 2006 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: